按需血压药物与退伍军人医院不良结局
这项回顾性队列研究采用目标试验模拟和倾向评分匹配,纳入2015年10月1日至2020年9月30日在退伍军人事务医院住院≥3天的成年退伍军人,要求为非ICU内科或外科病房、未接受手术、入院24小时内至少使用1种 scheduled 血压药物、住院期间至少1次收缩压>140 mm Hg。共133,760例符合分析(平均年龄71.2岁,96%男性),21%(28,526例)接受按需血压药物。按需血压药物使用与AKI风险增加相关(校正HR 1.23,95%CI 1.18-1.29),静脉途径亚组风险更高;使用者快速血压下降风险为1.5倍(95%CI 1.39-1.62),复合终点(心肌梗死、卒中或死亡)发生率为1.69倍(95%CI 1.49-1.92)。作者认为该关联需前瞻性试验确定风险获益,现有数据提示存在进行此类试验所需的均衡性。
要点
- 在133,760例住院退伍军人中,21%(28,526例)接受按需血压药物,与AKI风险增加相关(校正HR 1.23,95%CI 1.18-1.29)。
- 亚组分析显示静脉按需血压药物(相比口服或口服联合静脉途径)AKI风险更高。
- 按需血压药物使用者快速血压下降(给药后3小时内收缩压下降>25%)风险为1.5倍(95%CI 1.39-1.62)。
- 按需血压药物使用者心肌梗死、卒中或死亡复合终点发生率为1.69倍(95%CI 1.49-1.92)。
- 作者认为按需血压药物的风险获益最好通过前瞻性试验确定,现有数据提示存在进行此类试验所需的均衡性。
适用人群与场景
- 纳入:2015年10月1日至2020年9月30日在退伍军人事务医院住院≥3天的成年退伍军人;住院于非ICU内科或外科病房;未接受手术;入院24小时内至少使用1种 scheduled 血压药物;住院期间至少1次收缩压>140 mm Hg。
- 排除:ICU住院、接受手术、入院24小时内未使用 scheduled 血压药物、住院期间无收缩压>140 mm Hg。
研究设计与关键结果
- 研究类型:回顾性队列研究,采用目标试验模拟和倾向评分匹配;样本量133,760例;人群为成年退伍军人(平均年龄71.2岁,96%男性,基线eGFR均值75.7 mL/min/1.73m²);21%(28,526例)接受按需血压药物。
- 主要终点:按需血压药物使用者与非使用者相比,AKI风险增加(校正HR 1.23,95%CI 1.18-1.29)。
- 亚组分析:静脉按需血压药物(相比口服或口服联合静脉途径)AKI风险更高。
- 次要终点:按需血压药物使用者快速血压下降(给药后3小时内收缩压下降>25%)风险为1.5倍(95%CI 1.39-1.62);心肌梗死、卒中或死亡复合终点发生率为1.69倍(95%CI 1.49-1.92)。
证据类型、等级与局限
- 证据类型:回顾性队列研究(目标试验模拟)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,按需血压药物的风险与获益最好通过前瞻性试验确定,现有数据提示存在进行此类试验所需的均衡性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Asymptomatic blood pressure (BP) elevations in the hospital are commonly treated with as-needed BP medications, including recurring as-needed and 1-time administration. Veterans represent a population at risk of ischemic events from rapid lowering of BP, but the impact of as-needed BP medication use in this population is unknown.
OBJECTIVE: To assess the risks of acute kidney injury (AKI) and other outcomes from as-needed BP medication administration in a hospitalized veteran cohort.
DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study using target trial emulation and propensity score matching included adult veterans, who were hospitalized 3 or more days in Veterans Administration hospitals between October 1, 2015, and September 30, 2020. Participants must have been hospitalized on a non-intensive care unit medical or surgical floor, must not have undergone surgery, and must have received at least 1 scheduled BP medication in the first 24 hours of admission. Participants also must have had at least 1 systolic BP more than 140 mm Hg during hospitalization. Data in this study were analyzed from April 2023 to August 2024.
MAIN OUTCOMES AND MEASURES: The primary outcome was time to first AKI occurrence during hospitalization. Secondary outcomes included greater than 25% reduction in systolic BP within 3 hours of as-needed BP medication administration and the composite outcome of myocardial infarction, stroke, or death during hospitalization.
RESULTS: Of the 133 760 veterans eligible for analysis (mean [SD] age, 71.2 [11.6] years), 96% were male. The mean (SD) baseline estimated glomerular filtration rate was 75.7 (22.7) mL/min/1.73m2. A total of 28 526 patients (21%) received as-needed BP medication. As-needed BP medication use was associated with an increased AKI risk (adjusted hazard ratio, 1.23 [95% CI, 1.18-1.29]) compared to nonusers. Subgroup analyses showed higher AKI risk with intravenous as-needed BP medication use (compared to oral or combined oral and intravenous routes). Secondary analyses indicated as-needed BP medication users had a 1.5-fold greater risk of rapid BP reduction (95% CI, 1.39-1.62) and 1.69-fold higher rate of the composite outcome (95% CI, 1.49-1.92) compared to nonusers.
CONCLUSIONS AND RELEVANCE: The results of this retrospective cohort study showed that as-needed BP medication use among veterans is associated with increased AKI risk. The risks and benefits of this type of BP medication use would best be determined through a prospective trial, and these data suggest that there is the necessary equipoise to conduct such a trial.
参考来源
- Canales MT, Yang S, Westanmo A, et al. As-Needed Blood Pressure Medication and Adverse Outcomes in VA Hospitals. JAMA Intern Med. 2025. PMID: 39585709. doi:10.1001/jamainternmed.2024.6213
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。